Daniele Santini

32.2k total citations · 3 hit papers
618 papers, 15.1k citations indexed

About

Daniele Santini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Daniele Santini has authored 618 papers receiving a total of 15.1k indexed citations (citations by other indexed papers that have themselves been cited), including 417 papers in Oncology, 267 papers in Pulmonary and Respiratory Medicine and 131 papers in Molecular Biology. Recurrent topics in Daniele Santini's work include Colorectal Cancer Treatments and Studies (123 papers), Bone health and treatments (90 papers) and Cancer Treatment and Pharmacology (63 papers). Daniele Santini is often cited by papers focused on Colorectal Cancer Treatments and Studies (123 papers), Bone health and treatments (90 papers) and Cancer Treatment and Pharmacology (63 papers). Daniele Santini collaborates with scholars based in Italy, United States and United Kingdom. Daniele Santini's co-authors include Giuseppe Tonini, Bruno Vincenzi, Francesco Graziano, Antonio Russo, Francesco Pantano, Annamaria Ruzzo, Mauro Magnani, Gaia Schiavon, Carla Ripamonti and Stefano Cascinu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Daniele Santini

582 papers receiving 14.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bone health in cancer: ESMO Clinical Practice Guidelines

2020 294 citations Daniele Santini et al. profile →
The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline

2022 227 citations Carla Ripamonti, Daniele Santini et al. profile →
Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline

2023 88 citations Luigi Grassi, Daniele Santini et al. ESMO Open profile →

Peers

Countries citing papers authored by Daniele Santini

Since Specialization

Citations

This map shows the geographic impact of Daniele Santini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniele Santini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniele Santini more than expected).

Fields of papers citing papers by Daniele Santini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniele Santini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniele Santini. The network helps show where Daniele Santini may publish in the future.

Co-authorship network of co-authors of Daniele Santini

This figure shows the co-authorship network connecting the top 25 collaborators of Daniele Santini. A scholar is included among the top collaborators of Daniele Santini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniele Santini. Daniele Santini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pain Assessment and Management in Oncological Practice: A Survey from the Italian Network of Supportive Care in Oncology 2025 ·Healthcare ·Andrea Antonuzzo, Silvia Gonella, Livio Blasi, Simona Carnio, Ciro Franzese, Luigi Marano, Daniele Santini, Paolo Bossi	1
2	Impact of Molecular Androgen and Estrogen Response Scores on Outcomes Following Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer 2025 ·Clinical Cancer Research ·Valentina Tateo, Joep J. de Jong, (unknown), Brigida Anna Maiorano, (unknown), (unknown), Patrizia Giannatempo, Maurizio Colecchia, Marco Moschini, (unknown), Daniele Santini, Elai Davicioni, Alberto Briganti, Francesco Montorsi, Andrea Necchi	0
3	CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line 2024 ·Journal of Translational Medicine ·Alain Gelibter, (unknown), Lidia Strigari, Ilaria Grazia Zizzari, (unknown), Fabio Scirocchi, Angelica Pace, (unknown), (unknown), (unknown), Filippo Bellati, Andrea Botticelli, Donatella Paoli, Daniele Santini, Marianna Nuti, Aurelia Rughetti, Chiara Napoletano	7
4	Communication and support of patients and caregivers in chronic cancer care: ESMO Clinical Practice Guideline 2024 ·ESMO Open ·Friedrich Stiefel, Céline Bourquin, Peter Salmon, (unknown), S. Dauchy, Nicole Ernstmann, Luigi Grassi, Yves Libert, Frank Vitinius, Daniele Santini, Carla Ripamonti	13
5	The role of CD73 in predicting the response to immunotherapy in head and neck cancer patients 2024 ·Pathology - Research and Practice ·Andrea Botticelli, Alessio Cirillo, Giulia d’Amati, Cira Di Gioia, Alessandro Corsi, Carlo Della Rocca, Daniele Santini, Raffaella Carletti, Annalinda Pisano, Antonella Polimeni, Marco de Vincentiis, Valentino Valentini, Claudio Di Cristofano, Umberto Romeo, (unknown), Daniela Messineo, Francesca De Felice, Martina Leopizzi, Bruna Cerbelli	2
6	Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis 2024 ·BMC Cancer ·Alessio Cirillo, Daniele Marinelli, Umberto Romeo, Daniela Messineo, Francesca De Felice, Marco de Vincentiis, Valentino Valentini, Silvia Mezi, (unknown), (unknown), (unknown), Bruna Cerbelli, Daniele Santini, Paolo Bossi, Antonella Polimeni, Paolo Marchetti, Andrea Botticelli	4
7	Survival trends over 20 years in patients with advanced cholangiocarcinoma: Results from a national retrospective analysis of 922 cases in Italy 2023 ·Frontiers in Oncology ·Andrea Casadei‐Gardini, Francesco Leone, Giovanni Brandi, Mario Scartozzi, Nicola Silvestris, Daniele Santini, Luca Faloppi, Massimo Aglietta, Maria Antonietta Satolli, Alessandro Rizzo, Sara Lonardi, Giuseppe Aprile, Lorenzo Fornaro	1
8	Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal Cancer 2023 ·Cells ·Valentina Magri, Luca Marino, Chiara Nicolazzo, Angela Gradilone, (unknown), (unknown), Orietta Gandini, (unknown), Daniele Santini, Enrico Cortesi, Paola Gazzaniga	15
9	Breaking barriers in triple negative breast cancer (TNBC) – Unleashing the power of antibody-drug conjugates (ADCs) 2023 ·Cancer Treatment Reviews ·(unknown), Grazia Arpino, Giampaolo Bianchini, Giuseppe Curigliano, Romano Danesi, Michelino De Laurentiis, Lucia Del Mastro, Alessandra Fabi, Daniele Generali, Alessandra Gennari, Valentina Guarneri, Daniele Santini, Edda Simoncini, Claudio Zamagni, Fabio Puglisi	32
10	Evaluation of Efficacy of ALK Inhibitors According to Body Mass Index in ALK Rearranged NSCLC Patients—A Retrospective Observational Study 2023 ·Cancers ·(unknown), Gabriella Gentile, S Caponnetto, Isabella Sperduti, Daniele Santini, Enrico Cortesi, Alain Gelibter	5
11	A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors 2023 ·Frontiers in Immunology ·Silvia Mezi, Giulia Pomati, Giulia Fiscon, (unknown), Ilaria Grazia Zizzari, Chiara Napoletano, Aurelia Rughetti, Ernesto Rossi, Giovanni Schinzari, Giampaolo Tortora, Gaetano Lanzetta, Giulia d’Amati, Marianna Nuti, Daniele Santini, Andrea Botticelli	0
12	Palliative sedation and time to death in home palliative care: retrospective analysis 2023 ·BMJ Supportive & Palliative Care ·Daniele Marinelli, (unknown), (unknown), (unknown), Marco Filetti, Daniele Santini, Giampiero Porzio, Raffaele Giusti	1
13	Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer 2023 ·International Journal of Molecular Sciences ·Maria Concetta Cursano, Emilio Francesco Giunta, Emanuela Scarpi, Chiara Casadei, (unknown), Paola Ulivi, (unknown), Nicole Brighi, (unknown), Francesco Pantano, Vincenza Conteduca, Daniele Santini, Ugo De Giorgi	3
14	Deep Learning Algorithm Trained with COVID-19 Pneumonia Also Identifies Immune Checkpoint Inhibitor Therapy-Related Pneumonitis 2021 ·Cancers ·Carlo Augusto Mallio, Andrea Napolitano, (unknown), Francesco Giordano, (unknown), (unknown), (unknown), Silvia Angeletti, Marco Russano, Daniele Santini, Giuseppe Tonini, Bruno Beomonte Zobel, Bruno Vincenzi, Carlo Cosimo Quattrocchi	22
15	Cabozantinib Affects Osteosarcoma Growth Through A Direct Effect On Tumor Cells and Modifications In Bone Microenvironment 2018 ·Scientific Reports ·Marco Fioramonti, Valentina Fausti, Francesco Pantano, Michele Iuliani, Giulia Ribelli, Fiorenza Lotti, Ymera Pignochino, Giovanni Grignani, Daniele Santini, Giuseppe Tonini, Bruno Vincenzi	38
16	Classification of M1/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis 2017 ·Scientific Reports ·Francesca Romana Bertani, Pamela Mozetic, Marco Fioramonti, Michele Iuliani, Giulia Ribelli, Francesco Pantano, Daniele Santini, Giuseppe Tonini, Marcella Trombetta, Luca Businaro, S. Selci, Alberto Rainer	178
17	Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain 2015 ·Journal of Clinical Oncology ·Elena Bandieri, Marilena Romero, Carla Ripamonti, Fabrizio Artioli, (unknown), Caterina Fanizza, Daniele Santini, Luigi Cavanna, Barbara Melotti, Pierfranco Conté, Fausto Roila, Stefano Cascinu, Éduardo Bruera, Gianni Tognoni, Mario Luppi, (unknown)	96
18	Emerging kinase inhibitors of the treatment of gastric cancer 2015 ·Expert Opinion on Emerging Drugs ·Bruno Vincenzi, Marco Imperatori, Marianna Silletta, (unknown), Daniele Santini, Giuseppe Tonini	12
19	Carcinogenesis of Pancreatic Adenocarcinoma: Precursor Lesions 2013 ·International Journal of Molecular Sciences ·Antonio Gnoni, Antonella Licchetta, Aldo Scarpa, Amalia Azzariti, Anna Elisabetta Brunetti, Gianni Simone, Patrizia Nardulli, Daniele Santini, Michele Aieta, Sabina Delcuratolo, Nicola Silvestris	50
20	Tumor markers in colorectal cancer 1995 ·Journal of Experimental & Clinical Cancer Research ·M. G. Reale, Daniele Santini, S Chiodini, Paolo Izzo, (unknown), Luigi Frati	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact